Cargando…
Hashimoto Encephalopathy: A Rare Intricate Syndrome
Recently, several patients have been reported with various signs of encephalopathy and high thyroid antibody levels together with good responsiveness to glucocorticoid therapy. Despite the various clinical presentations, these cases have been termed “Hashimoto encephalopathy” (HE). Although all of t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693614/ https://www.ncbi.nlm.nih.gov/pubmed/23843812 http://dx.doi.org/10.5812/ijem.4174 |
_version_ | 1782274735404482560 |
---|---|
author | Payer, Juraj Petrovic, Tomas Lisy, Lubomir Langer, Pavel |
author_facet | Payer, Juraj Petrovic, Tomas Lisy, Lubomir Langer, Pavel |
author_sort | Payer, Juraj |
collection | PubMed |
description | Recently, several patients have been reported with various signs of encephalopathy and high thyroid antibody levels together with good responsiveness to glucocorticoid therapy. Despite the various clinical presentations, these cases have been termed “Hashimoto encephalopathy” (HE). Although all of the pathogenic components have not yet been clearly elucidated, it is believed that brain vasculitis and autoimmunity directed against common brain-thyroid antigens represent the most likely etiologic pathway. The most common clinical signs include unexplained or epilepsy-like seizures resistant to anti-convulsive treatment, confusion, headaches, hallucinations, stroke-like episodes, coma, impairment of cognitive function, behavioral and mood disturbance, focal neurological deficits, disturbance of consciousness, ataxia, and presenile dementia, together with the presence of high thyroid antibody levels, especially against thyroperoxidase (TPOab). In most cases, the thyroid function is normal or decreased; the thyroid function is rarely increased. The examination of the cerebrospinal fluid, EEG, MRI, SPECT, and neuropsychological examinations are primarily used as diagnostic tools. Most cases showed neural symptoms for months before the acute onset; in some cases, a dramatic acute onset was described. Once the diagnosis is made, corticosteroid treatment usually provides a dramatic recovery. The authors also present a short review of literary cases reported in last decade. |
format | Online Article Text |
id | pubmed-3693614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Kowsar |
record_format | MEDLINE/PubMed |
spelling | pubmed-36936142013-07-10 Hashimoto Encephalopathy: A Rare Intricate Syndrome Payer, Juraj Petrovic, Tomas Lisy, Lubomir Langer, Pavel Int J Endocrinol Metab Case Report Recently, several patients have been reported with various signs of encephalopathy and high thyroid antibody levels together with good responsiveness to glucocorticoid therapy. Despite the various clinical presentations, these cases have been termed “Hashimoto encephalopathy” (HE). Although all of the pathogenic components have not yet been clearly elucidated, it is believed that brain vasculitis and autoimmunity directed against common brain-thyroid antigens represent the most likely etiologic pathway. The most common clinical signs include unexplained or epilepsy-like seizures resistant to anti-convulsive treatment, confusion, headaches, hallucinations, stroke-like episodes, coma, impairment of cognitive function, behavioral and mood disturbance, focal neurological deficits, disturbance of consciousness, ataxia, and presenile dementia, together with the presence of high thyroid antibody levels, especially against thyroperoxidase (TPOab). In most cases, the thyroid function is normal or decreased; the thyroid function is rarely increased. The examination of the cerebrospinal fluid, EEG, MRI, SPECT, and neuropsychological examinations are primarily used as diagnostic tools. Most cases showed neural symptoms for months before the acute onset; in some cases, a dramatic acute onset was described. Once the diagnosis is made, corticosteroid treatment usually provides a dramatic recovery. The authors also present a short review of literary cases reported in last decade. Kowsar 2012-04-20 2012 /pmc/articles/PMC3693614/ /pubmed/23843812 http://dx.doi.org/10.5812/ijem.4174 Text en Copyright © 2012, Research Institute For Endocrine Sciences and Iran Endocrine Society http://creativecommons.org/licenses/by/3/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Payer, Juraj Petrovic, Tomas Lisy, Lubomir Langer, Pavel Hashimoto Encephalopathy: A Rare Intricate Syndrome |
title | Hashimoto Encephalopathy: A Rare Intricate Syndrome |
title_full | Hashimoto Encephalopathy: A Rare Intricate Syndrome |
title_fullStr | Hashimoto Encephalopathy: A Rare Intricate Syndrome |
title_full_unstemmed | Hashimoto Encephalopathy: A Rare Intricate Syndrome |
title_short | Hashimoto Encephalopathy: A Rare Intricate Syndrome |
title_sort | hashimoto encephalopathy: a rare intricate syndrome |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693614/ https://www.ncbi.nlm.nih.gov/pubmed/23843812 http://dx.doi.org/10.5812/ijem.4174 |
work_keys_str_mv | AT payerjuraj hashimotoencephalopathyarareintricatesyndrome AT petrovictomas hashimotoencephalopathyarareintricatesyndrome AT lisylubomir hashimotoencephalopathyarareintricatesyndrome AT langerpavel hashimotoencephalopathyarareintricatesyndrome |